DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 133 filers reported holding DIPLOMAT PHARMACY INC in Q2 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $9,832,000 | -11.9% | 2,457,976 | +8.0% | 0.00% | 0.0% |
Q3 2019 | $11,154,000 | -18.1% | 2,276,188 | +1.7% | 0.00% | -20.0% |
Q2 2019 | $13,625,000 | +4.0% | 2,237,307 | -0.8% | 0.01% | 0.0% |
Q1 2019 | $13,098,000 | -54.3% | 2,254,474 | +5.9% | 0.01% | -61.5% |
Q4 2018 | $28,650,000 | -14.8% | 2,128,358 | +22.8% | 0.01% | 0.0% |
Q3 2018 | $33,639,000 | +7.9% | 1,733,112 | +42.2% | 0.01% | +8.3% |
Q2 2018 | $31,163,000 | +19.3% | 1,219,143 | -6.0% | 0.01% | +9.1% |
Q1 2018 | $26,124,000 | -0.9% | 1,296,457 | -1.3% | 0.01% | 0.0% |
Q4 2017 | $26,355,000 | +42.2% | 1,313,081 | +46.8% | 0.01% | +37.5% |
Q3 2017 | $18,528,000 | +249.5% | 894,669 | +149.7% | 0.01% | +300.0% |
Q2 2017 | $5,302,000 | +9.5% | 358,257 | +18.0% | 0.00% | 0.0% |
Q1 2017 | $4,842,000 | +26.5% | 303,596 | -0.0% | 0.00% | 0.0% |
Q4 2016 | $3,827,000 | -53.2% | 303,696 | +4.1% | 0.00% | -50.0% |
Q3 2016 | $8,172,000 | +534.5% | 291,794 | +693.2% | 0.00% | +300.0% |
Q2 2016 | $1,288,000 | – | 36,788 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
Investors Research Corp | 89,727 | $546,000 | 0.28% |
Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |